| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea9be92fae64999a0a52aa6fb7bf74a5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 |
| filingDate |
1998-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2000-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04630d8a024ec79428d1e3d497d83153
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a43d565fd146154deb82b616a2db9d72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff22e4af273a1527bed016212ef98bc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_586f7a9ef9ab46a3e30bc7187acf0ed3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_438699ffa2ebce20ee27ee02a1525e0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba530656d5b3bff5fc2fb7fc3d425e30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8137e8a1083681bda3fe4da95e3b4a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eda3ae60aac70eb6654c4affc34728a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62b837928f38e7d479651a0512d5ba7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5805b22da0d51ded5bdfdc326a7b926 |
| publicationDate |
2000-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-100263313-B1 |
| titleOfInvention |
New human N-acetylglucosamine transcriptase V gene and method for preparing active enzyme using same |
| abstract |
The present invention novel N - relates to a process for preparing a-acetylglucosamine transferase V (N-acetylglucosaminyl transferase V) gene and the N- acetylglucosamine transferase using the same. Specifically, the present invention is activated by mass expression in E. coli in the form of a new gene of N-acetylglucosamine transferase V and a transmembrane domain which are expressed only in cancer cells which are not expressed in normal cells but only in highly metastatic cancer cells. The present invention relates to a method for purifying an enzyme, which may be usefully used for the production of antibodies for diagnosing cancer and the development of specific activity inhibitors for treating cancer. |
| priorityDate |
1998-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |